致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Mouse Integrin alpha 2B beta 3 (ITGA2B&ITGB3) Heterodimer, His-tag
目录号 NBL-242416
别名 Integrin alpha 2B beta 3 (ITGA2B&ITGB3) Heterodimer; ITGA2B&ITGB3; ITGA2B; ITGB3
外观 see COA
分子量 Leu32-Arg988(ITGA2B) acidic tail & Glu26-Asp717(ITGB3) basic tail
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 Q9QUM0(ITGA2B)&O54890(ITGB3)
备注2
目录号 规格 价格 库存状态  
NBL-242416-100ug 100ug Inquire Inquire
NBL-242416-1mg 1mg Inquire Inquire
NBL-242416-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Mouse Integrin alpha 2B beta 3 (ITGA2B&ITGB3) Heterodimer, His-tag


Catalog#:

NBL-242416


Description:

NebuSelect™ Recombinant Mouse Integrin alpha 2B beta 3 (ITGA2B&ITGB3) Heterodimer, His-tag(Cat#NBL-242416) is expressed in HEK293 with His tag at the C-Terminus.It contains Leu32-Arg988 (ITGA2B) acidic tail and Glu26-Asp717 (ITGB3) basic tail.


Species:

Mouse


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 109.80 kDa (ITGA2B) and 80.80 kDa (ITGB3). Due to glycosylation, the protein migrates to 90-113 kDa based on Bis-Tris PAGE result.


Target Name:

Integrin alpha 2B beta 3 (ITGA2B&ITGB3) Heterodimer; ITGA2B&ITGB3; ITGA2B; ITGB3


Target Information:

Glanzmann thrombasthenia (GT) is characterized by mucocutaneous bleeding due to platelets that fail to aggregate in response to physiologic stimuli. GT, a rare inherited disease, is caused by quantitative or qualitative deficiencies of αIIbβ3, an integrin receptor for adhesive proteins. Coded by the ITGA2B and ITGB3 genes, αIIbβ3 mediates platelet-to-platelet attachment, aggregation and clot retraction.


Amino Acid Sequence: 

Leu32-Arg988(ITGA2B) acidic tail & Glu26-Asp717(ITGB3) basic tail


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品